Suil Vision has launched with £500k of seed funding from Cancer Research Horizons. The new company aims to create a market-ready biological data visualisation tool for researchers.

Arecor presents data from trial of ultra-concentrated, ultra-rapid acting insulin in overweight and obese people.

Twenty-three companies will benefit from a share of £12 million from the Innovate UK Cancer Therapeutics programme. The Cancer Therapeutics programme focuses on developing life-changing cancer treatments, including immunotherapies and vaccines. It also supports projects addressing unmet medical needs for treating childhood and young persons’ cancers.

This week I’ve been engaging with City and Government figures seeking to develop practical measures enabling UK life science to deliver our full growth potential. The key autumn dates remain the Government’s International Investment Summit on 14 October and the Budget on 30 October but the debate about what should be in this is already well underway.

Greig Rooney, Managing Director at Valneva Scotland, writes about his experience getting malaria as a child and its impact on his life.

It’s a back-to-school feel with a bang for me this week as the landscape of the Association’s work til Christmas comes into sharp focus. Read on for our proposals for a sector-by-sector approach to analyse the effectiveness of R&D tax reliefs, turning health into economic growth, pandemics and more!